Today in History for Feb. 17: ...

The split will allow WBD to take advantage of "broader market opportunities" as they arise, CEO David Zaslav told analysts.

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, the company’s earnings beat estimates by 12.64%. The Zacks Consensus ...

Novavax reported a Q4 2024 EPS of -$0.51, surpassing expectations. Revenue for the quarter fell to $88.3 million, missing forecasts and down from $291 million in Q4 2023. The company reduced R&D ...

Novavax (NVAX) ended the recent trading session at $7.92, demonstrating a -1.25% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.43%.

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%. Feb-25 8.5 calls and Mar-25 7.5 puts are the most active ...

Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic. Novavax (NVAX) closed the most recent trading day at $7.92, moving -1.25% from the ...

Australia has banned DeepSeek from all government devices over concerns that the Chinese artificial intelligence startup behind it poses security risks, the government said Tuesday. The Secretary ...